A recent study on the application of metagenomic next-generation sequencing (mNGS) found that mNGS can achieve early ...

Researchers from the University of Melbourne and Murdoch Children's Research Institute (MCRI) have developed a blood test ...

Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it ...

GeneDx delivered strong Q1 2025 results, beating revenue and EPS estimates, and raised full-year guidance. The test volume ...

Whole genome sequencing and whole exome sequencing are gaining widespread use as research tools and are now also being used as a clinical test. This powerful sequencing has the potential to discover ...

With Aura, genetic test results are seamlessly integrated ... the adoption of genome and exome sequencing will continue to grow, further incorporating genetic insights into routine clinical ...

The company describes the precision medicine test as the first of its kind to offer simultaneous whole exome sequencing and whole transcriptome sequencing—with the ability to parse mutations in ...

Overall, our results support the use of genome sequencing as a first-line test for the diagnosis of rare diseases, replacing both exome sequencing and chromosomal microarray in a single test ...

starting with a microarray test before progressing to a broader genome-wide sequencing test (such as exome or genome sequencing). In this new study, scientists set out to develop a single approach to ...

Proposals to remove confirmatory testing, which would reduce the costs of this test, are under consideration. Whole-exome sequencing clinical genetics – a health economic evaluation is free to ...